Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Antibodies
Nucleic acid drugs
Antibody-drug-conjugate
Indications:
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Musculoskeletal system and connective tissue / Orthopedics
Products
In development: 8
Description:
Avidity Biosciences is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™). The company's product Del-desiran (AOC 1001) utilizing AOC platform technology, is designed to address the genetic cause of DM1 by reducing levels of toxic DMPK mRNA. The company's another product Del-brax is an Antibody Oligonucleotide Conjugate (AOC) that targets the DUX4 gene, which is the underlying cause of Facioscapulohumeral Muscular...
